Clinical Trials
12 trialsNCT05484570 2026-05-27
Natural History Study for DNA Repair Disorders
University of Minnesota
Recruiting
NCT00001813 2026-05-07
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
National Institutes of Health Clinical Center (CC)
Completed
NCT04500548 2025-09-10
Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study
National Cancer Institute (NCI)
Phase 1 Withdrawn
NCT06330324 2025-05-18
REPRO-ISD
Maastricht University Medical Center
Enrolling by invitation
NCT00046189 2024-01-08
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
National Institutes of Health Clinical Center (CC)
Completed
NCT05370235 2023-09-21
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V
Clinuvel Pharmaceuticals Limited
Phase 2 Unknown
NCT05159752 2023-06-18
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
Clinuvel Pharmaceuticals Limited
Phase 2 Unknown
NCT04155190 2023-05-31
An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC
Sol-Gel Technologies, Ltd.
Phase 2 Terminated
NCT03445052 2020-07-22
XPAND
Guy's and St Thomas' NHS Foundation Trust
Phase NA Completed
NCT03662828 2019-05-14
KAPOSI-1
Direction Centrale du Service de Santé des Armées
Unknown
NCT01123694 2010-05-14
Xeroderma Pigmentosum Patient Experiences
Henry Ford Health System
Unknown
NCT00555633 2009-09-30
Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
Medical University of Graz
Completed